For the year ending 2025-12-31, CBLL had -$153,894K decrease in cash & cash equivalents over the period. -$41,575K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -53,412 |
| Depreciation and amortization expense | 1,341 |
| Noncash lease expense | 101 |
| Stock-based compensation expense | 12,223 |
| Amortization of debt discount and accretion of premium on term loans | 415 |
| Accretion (amortization) of discount and premium on marketable securities | 2,011 |
| Change in fair value of warrant liability | 0 |
| Loss on disposal of property and equipment and recorders | -104 |
| Accounts receivable, net | 4,175 |
| Inventory | 351 |
| Prepaid expenses and other current assets | -345 |
| Contract costs | 713 |
| Other non-current asset | 415 |
| Accounts payable | 1,745 |
| Accrued liabilities and other current liabilities | 4,223 |
| Contract liabilities | -26 |
| Net cash used in operating activities | -40,808 |
| Purchases of recorder components and recorders | 755 |
| Purchases of property and equipment | 767 |
| Purchases of marketable securities | 210,815 |
| Proceeds from maturities of marketable securities | 94,200 |
| Net cash used in investing activities | -118,137 |
| Proceeds related to employee stock plans | 5,437 |
| Taxes withheld and paid related to settlement or vesting of equity awards | 236 |
| Proceeds from debt issuance | 0 |
| Debt issuance cost | 150 |
| Payment of deferred ipo offering costs | 0 |
| Proceeds from ipo, net of commissions | 0 |
| Net cash provided by financing activities | 5,051 |
| Net increase (decrease) in cash and cash equivalents | -153,894 |
| Cash and cash equivalents, beginning of period | 194,370 |
| Cash and cash equivalents, end of period | 40,476 |
Ceribell, Inc. (CBLL)
Ceribell, Inc. (CBLL)